![]()
- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- Big Stock Upside for Hudson City Deal: Analyst
- 5 High-Yield Stocks Ready to Boost Dividends
- Option Bulls Take Another Shot on Idenix
- Top 20 European Stocks for Crisis Time: Strategist
- Hewlett-Packard Faces a ‘Dogfight’ for Talent: Analyst
- DuckDuckGo Cooks Google’s Goose: Analyst
- General Electric’s $4.5 Billion Dividend Slated for Buybacks
- Dell Has Worst Day in 11 Years, Volume Jumps
- What Would it Take for Facebook to Eclipse Visa's Record IPO?
- Gold Turns Negative for 2012
- The Worst-Performing Energy Stocks This Week
- Papa Johns Hits Record High, Volume Spikes
- S&P 500 Earnings: Biggest Surprises
- Big Lots Has Worst Day Since 2008, Breaks Technical Level
- BP Oil Disaster: Two Years Later
- eBay Has Best Day Since 2008, Volume Spikes
- Here are Today's Winners on the Biotech Index
- Citigroup Lost $20 Million on Facebook IPO Trades
- Sticker Shock: What College Is Likely to Cost in 18 Years
- JPMorgan to Shake Up Risk Team After Big Loss: Report
- Icahn Raises Stake in Chesapeake, Wants Board Seats
- Marc Faber: Chance of Global Recession Is Now 100%
- Week Ahead: Europe Has Wall Street Bull on Short Leash
- What Happened to Stocks? Most Unloved in 50 Years
- Cool Jobs: From Gold Stacker to Bed Tester
- Many Greeks Moved Their Money Abroad Long Ago
MOST SHARED
- Marc Faber: 100% Chance of Global Recession
- Time for Flash Sales to Adapt or Die
- Don’t Trust Buybacks
- Buy Broken Stocks, Not Broken Companies
- The Biggest Market Myth There Is?
- Citigroup Lost $20 Million on Facebook IPO Trades
- Romney Leads Poll Of Small Business Owners
- Buying the Right Sell-Off Stocks
- How to Trade on the Jobs Report
- Under Pressure, FHA Skews to Wealthier Home Buyers
MOST POPULAR
HOT ON FACEBOOK
Recession Nerves = Great Buying Opportunity
![]() |
David Spika, WHG Funds vice president, isn't afraid to use the "R" word -- but he's no bear. He thinks the recession talk is overdone, making now a great time to buy stocks.
Jeff Krumpelman of Fifth Third Asset Management also hears opportunity knocking.
"I think the market is confused and nervous about how far left or right we are of zero," Krumpelman told CNBC.
"So we'll have continued volatility while it's figuring that out. But if you ask me over the next nine to 12 months if I thought this is a good time to be building positions, absolutely, I think it is."
"The market's pretty much priced into a recession, and priced into a pretty significant recession," Spika said. "Regardless of whether we have one, now is a good time to buy."
So what buys look good? He likes The Walt Disney Co. [DIS
Loading...
()
]
"If the economy goes into a significant, protracted recession, consumer-related stocks are going to get hurt -- but we don't think that's the case, and Disney's trading at a 20-year low valuation right now," Spika said.
"We think we'd be stupid not to be buying it here."
Krumpelman's confidence extends all the way to biotechnology. One biotech stock that he likes even better than pharmaceuticals: Celgene [CELG
Loading...
()
].
"I think it's misleading just to say, let's flock to large-cap pharmaceutical companies that have very unimpressive growth rates." he said. "I feel much safer with...Celgene."
He said the company "has a strong franchise, with a 35 percent growth profile."







